National Institute for Health and Care Excellence Single Technology Appraisal (STA) Gilteritinib for treating relapsed or refractory acute myeloid leukaemia (ID1484) Response to consultee and commentator comments on the draft remit and draft scope (pre-referral) (revised June 2019)

№ files_lp_4_process_1_48769

File format: docx Character count: 14803 File size: 36 KB

This document presents responses to stakeholder comments regarding the draft remit and scope for evaluating gilteritinib as a treatment for relapsed or refractory acute myeloid leukaemia (AML).

Year: 2019

Region / City: United Kingdom

Topic: Cancer, Hematology

Document Type: Response to Consultation

Organization: National Institute for Health and Care Excellence (NICE)

Author: National Institute for Health and Care Excellence (NICE)

Target Audience: Healthcare professionals, policy makers

Effective Period: Not specified

Approval Date: Not specified

Amendment Date: June 2019

By placing an order, you agree to the Terms of Use and acknowledge that access to digital materials is provided after payment and is non-refundable, except in cases where the material is not actually accessible.

Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:

Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
In the app, tap Send.
Select network, paste our wallet address.
Send the exact amount shown above.

After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.

The Quranic Commentator in the Age of AI: Bridging Theology, Science, Philosophy, Psychology, and Sociology

Year: 2023

Region / City: Global

Topic: Artificial Intelligence, Quranic Commentary, Theology, Philosophy, Science, Psychology, Sociology

Document Type: Academic Article

Author: Zia H Shah MD

Target Audience: Scholars, Theologians, Researchers, Students of Islamic Studies, AI enthusiasts

Period of Validity: Ongoing

Approval Date: Not specified

Date of Changes: Not specified

Topics: Gilteritinib ID1484 commentator

The project is focused on storing and searching highly specialized data that is rarely indexed by major search engines.

The content of this website is protected under applicable copyright laws, including but not limited to the Copyright Act and relevant legislation of the European Union. Any use of the content, including reproduction, distribution, public communication, modification, or other processing, is prohibited without the prior written consent of the rights holder, unless expressly permitted by law. Users are permitted to use the content solely for personal purposes within the scope defined by copyright legislation. Any other use, including commercial use, requires the prior written authorization of the rights holder. Trademarks, trade names, logos, and other identifiers displayed on this website may be registered trademarks of their respective owners. Any use without the authorization of the relevant rights holder is prohibited. The website operator does not guarantee the accuracy, completeness, or timeliness of the information provided and shall not be liable for any damage or loss resulting from its use, except where required by mandatory legal provisions.

Reproduction of materials is permitted only if a link to speakdot.com is included.